Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7
2019 · Cell Death and Disease · 179 citations
https://doi.org/10.1038/s41419-019-1660-8
X
Xufeng Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
1.3K
Citations
21
h-index
35
i10-index
Xufeng Pan is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations & RNA modifications and cancer. The author has an h-index of 21, co-authored 60 publications.
Papers by this author
worksTRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells
2022 · Cell Death and Disease · 59 citations
https://doi.org/10.1038/s41419-022-04727-7
Transitional CXCL14<sup>+</sup> cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
2025 · Clinical and Translational Medicine · 10 citations
https://doi.org/10.1002/ctm2.70281
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat